FiberCell Systems Inc.

FiberCell Systems Inc. is the leading supplier of hollow fiber bioreactors to the biomedical research community. Their hollow fiber bioreactors are preferred for the production of secreted products from mammalian cells, including monoclonal antibodies, recombinant proteins, secretome, and extracellular vesicles. This technology enables laboratories to easily scale up their cell culture methods. The company also offers CDM HD, a chemically defined, cGMP compliant serum replacement optimized for use in high-density cultures, such as those found in a hollow fiber bioreactor. Founded in 2000, FiberCell Systems operates in the biotechnology, design, and manufacturing industries.

As of now, there is no information available about their headquarters, last investment, or last investment investors. More details about the company can be found on their website, www.fibercellsystems.com.

Overall, FiberCell Systems Inc. plays a crucial role in providing advanced bioreactor technology to the biomedical research community, catering to the growing demand for efficient and scalable cell culture methods.